Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
The era of value- and evidence-based care has come to oncology practice. Third-party payers approve treatment plans according to expert guidelines such as those of the National Comprehensive Cancer ...
Provider discussions about cardiovascular health factors by cancer type, provider type, and patient age (results from WF-1804CD). Optimizing the fairness of survival prediction models for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results